SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-007482
Filing Date
2020-05-11
Accepted
2020-05-11 16:54:10
Documents
102
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akrx-20200331.htm   iXBRL 10-Q 2163566
2 EX-31.1 exhibit311-03312020.htm EX-31.1 11578
3 EX-31.2 exhibit312-03312020.htm EX-31.2 11817
4 EX-32.1 exhibit321-03312020.htm EX-32.1 5598
5 EX-32.2 exhibit322-03312020.htm EX-32.2 5570
  Complete submission text file 0001628280-20-007482.txt   11345622

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20200331.xsd EX-101.SCH 78479
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20200331_cal.xml EX-101.CAL 124939
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20200331_def.xml EX-101.DEF 335800
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20200331_lab.xml EX-101.LAB 850520
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20200331_pre.xml EX-101.PRE 585303
54 EXTRACTED XBRL INSTANCE DOCUMENT akrx-20200331_htm.xml XML 2404896
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 20865736
SIC: 2834 Pharmaceutical Preparations